Skip to main content

Table 2 Copy number aberrations of SLC7A5 in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) breast cancer series and their association with clinicopathological parameters, MYC copy number aberrations and breast cancer subtypes

From: The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

SLC7A5 copy number

Gain

Loss

 

No,

number (%)

Yes,

number (%)

χ2 (p value)

Adjusted p value

No,

number (%)

Yes,

number (%)

χ2 (p value)

Adjusted p value

Age (years)

 ≥50

1520 (97.7)

36 (2.3)

0.405 (0.524)

1.572

1098 (70.6)

458 (29.4)

27.479 (1.5 × 10− 7)

<0.0001

 ˂50

372 (97.1)

11 (2.9)

321 (83.8)

62 (16.2)

Tumour size

 ≥2.0 cm

1291 (97.0)

40 (3.0)

5.226 (0.022)

0.132

976 (73.3)

355 (26.7)

0.094 (0.759)

0.282

 ˂2.0 cm

614 (98.7)

8 (1.3)

452 (72.7)

170 (27.3)

Tumour grade

 1

170 (100.0)

0 (0.0)

10.154 (0.006)

0.042

99 (58.2)

71 (41.8)

107.36 4.8 × 10−24

<0.0001

 2

756 (98.2)

14 (1.8)

495 (64.3)

275 (35.7)

 3

918 (96.4)

34 (3.6)

799 (83.9)

153 (16.1)

Lymph node stage

 1

1012 (97.8)

23 (2.2)

0.474 (0.789)

1.578

726 (70.1)

309 (29.9)

10.425 (0.005)

0.02

 2

606 (97.4)

16 (2.6)

480 (77.2)

142 (22.8)

 3

307 (97.2)

9 (2.8)

237 (75.0)

79 (25.0)

Nottingham Prognostic Index

 Good

668 (98.2)

12 (1.8)

2.602 (0.272)

0.080

418 (61.5)

262 (38.5)

76.132 (2.9 × 10−17)

<0.0001

 Moderate

1071 (97.3)

30 (2.7)

864 (78.5)

237 (21.5)

 Poor

192 (96.5)

7 (3.5)

168 (84.4)

31 (15.6)

Histological type

 Ductal

1500 (97.2)

44 (2.8)

6.880 (0.230)

1.150

1154 (74.7)

390 (25.3)

29.544 (0.00001)

0.0001

 Lobular

145 (98.6)

2 (1.4)

88 (59.9)

59 (40.1)

 Medullary

30 (93.8)

2 (6.3)

30 (93.8)

2 (6.2)

 Miscellaneous

12 (100.0)

0 (0.0)

9 (75.0)

3 (25.0)

 Special type

113 (100.0)

0 (0.0)

74 (66.8)

39 (33.2)

PAM50 subtype

 Luminal A

710 (98.9)

8 (1.1)

40.515 (3.3 × 10−8)

<0.0001

423 (58.9)

295 (41.1)

248.3 (1.4 × 10−52)

<0.0001

 Luminal B

477 (97.7)

11 (2.3)

312 (63.9)

176 (36.1)

 Basal

305 (92.7)

24 (7.3)

319 (97.0)

10 (3.0)

 HER2+

235 (97.9)

5 (2.1)

219 (91.3)

21 (8.7)

 Normal-like

198 (99.5)

1 (0.5)

172 (11.9)

27 (5.1)

MYC gain

 No

1228 (98.9)

14 (1.1)

25.0 (5.5 × 10−7)

<0.0001

1446 (73.3)

528 (26.7)

0.132 (0.716)

1.432

 Yes

703 (95.3)

35 (4.7)

4 (66.7)

2 (33.3)

  1. PAM50 prediction analysis of microarray, HER2 human epidermal growth factor receptor 2
  2. p value in bold in these tables means statistically significant associations